Senseonics Holdings Inc (NYSEAMERICAN:SENS)’s stock price fell 6.3% during mid-day trading on Friday . The stock traded as low as $0.47 and last traded at $0.48, 1,977,919 shares traded hands during trading. A decline of 26% from the average session volume of 2,682,142 shares. The stock had previously closed at $0.51.
Several research firms have recently issued reports on SENS. UBS Group cut their price target on Senseonics from $0.70 to $0.25 and set a “sell” rating for the company in a research note on Thursday, May 21st. BTIG Research reiterated a “hold” rating on shares of Senseonics in a research report on Wednesday, June 10th. Zacks Investment Research upgraded Senseonics from a “hold” rating to a “buy” rating and set a $0.50 price objective for the company in a research report on Saturday, June 13th. SVB Leerink dropped their price objective on Senseonics from $2.00 to $1.00 and set an “outperform” rating for the company in a research report on Wednesday, June 10th. Finally, Stifel Nicolaus dropped their price objective on Senseonics from $1.85 to $1.00 and set a “buy” rating for the company in a research report on Wednesday, June 10th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $0.99.
Senseonics (NYSEAMERICAN:SENS) last posted its quarterly earnings results on Tuesday, June 9th. The company reported ($0.21) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.09). The business had revenue of $0.03 million during the quarter, compared to the consensus estimate of $0.77 million.
A number of institutional investors and hedge funds have recently bought and sold shares of SENS. Geode Capital Management LLC grew its holdings in Senseonics by 11.2% in the 4th quarter. Geode Capital Management LLC now owns 1,693,382 shares of the company’s stock valued at $1,551,000 after buying an additional 169,879 shares during the period. State Street Corp grew its holdings in Senseonics by 6.5% in the 1st quarter. State Street Corp now owns 1,975,595 shares of the company’s stock valued at $1,252,000 after buying an additional 121,398 shares during the period. Marshall Wace LLP purchased a new stake in Senseonics in the 1st quarter valued at about $272,000. Beacon Pointe Advisors LLC acquired a new position in shares of Senseonics in the 1st quarter valued at about $62,000. Finally, Squarepoint Ops LLC acquired a new position in shares of Senseonics in the 1st quarter valued at about $47,000. Institutional investors own 30.66% of the company’s stock.
About Senseonics (NYSEAMERICAN:SENS)
Senseonics Holdings, Inc, a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes for a period of up to 90 and 180 days.
Featured Story: What is the Shanghai Stock Exchange Composite Index?
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.